CoffeeBerry
Protected by U.S. and International pending patent applications and issued patents, including U.S. patent 7,959,957; U.S. patent 7,815,959; U.S. patent 7,807,205; and U.S. patent 7,754,263. The CoffeeBerry® trademark and related pending patents are exclusively licensed by VDF FutureCeuticals, Inc.
Idebenone
*The Idebenone technology is protected by numerous US and International patents: AU 767 909, CA 2 375 537, CN ZL 00 809 884.0, EP 1 194 115, US 6, 756,045, ZA 2002/0053, HK 05 101 647.0, N0 2002-0071, BR PI 0011 958-0. Additional patents pending.
This groundbreaking anti-ageing collection features encapsulated Retinyl Retinoate, a breakthrough hybrid molecule combining Retinol and Retinoic Acid, that delivers better, faster results - even on sensitive skin.
Unlike ordinary Retinol, which should only be used at night, Retinyl Retinoate is photostable, so this product portfolio can be used both day and night to visibly rejuvenate skin. Eight years in development, Retinyl Retinoate is powerful but gentle, achieving clinically proven results after just four weeks' use. These advanced formulations soften fine lines and wrinkles, boost brightness and improve texture and tone, without any of the irritation often associated with traditional retinol products.